However, SPOP mutations led to enhanced LMNB2 degradation and disrupted NE integrity, causing nuclear rupture and making cancer cells more sensitive to farnesyltransferase inhibitor–based (FTI-based) therapies. This evidence concerns the gene LMNB2 and cancer.